Related Experiment Videos

Predicting changes in clinical status of young asthmatics: clinical scores or objective parameters?

Ting F Leung1, Fanny W S Ko, Gary W K Wong

  • 1Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. tfleung@cuhk.edu.hk

Pediatric Pulmonology
|April 22, 2009
PubMed

Insights

The Childhood Asthma Control Test (C-ACT) effectively predicts asthma exacerbations in young children. This simple tool outperforms traditional methods in assessing disease control and indicating changes in asthma status.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Clinical Assessment

Background:

  • Asthma exacerbations pose a significant challenge in pediatric asthma management.
  • Current clinical tools exhibit limitations in predicting asthma exacerbations among young children.
  • The Childhood Asthma Control Test (C-ACT) has emerged as a promising, simple assessment for pediatric asthma control.

Purpose of the Study:

  • To evaluate the utility of the C-ACT and other disease-related factors in tracking longitudinal asthma status changes.
  • To determine the predictive value of C-ACT for asthma exacerbations in children aged 4-11 years.
  • To compare the effectiveness of C-ACT against traditional measures like Disease Severity Score (DSS) and objective parameters.

Main Methods:

  • A cohort of 97 children (4-11 years) with asthma completed the Chinese version of C-ACT.
  • Exhaled nitric oxide and spirometry (FEV1) were measured during clinic visits.
  • Disease Severity Score (DSS) and Global Initiative for Asthma control ratings were assigned; exacerbations were recorded over 6 months.

Main Results:

  • C-ACT, DSS, and FEV1 showed significant differences across asthma control statuses (P < 0.001 for C-ACT/DSS, P = 0.028 for FEV1).
  • Changes in C-ACT scores correlated with changes in asthma control status, DSS, and FEV1 (P = 0.019-0.034).
  • Lower baseline C-ACT scores were associated with subsequent asthma exacerbations (P = 0.015), confirmed by logistic regression (P = 0.042).

Conclusions:

  • The C-ACT demonstrates superior ability compared to DSS and objective measures in reflecting asthma status changes in young children.
  • Baseline C-ACT scores are a significant predictor of future asthma exacerbations in this pediatric population.
  • C-ACT offers a valuable tool for improving asthma management and exacerbation prevention in children.

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.